For now, it doesn't seem likely CrowdStrike can generate millionaire-making gains. It's still a decent play on the secular ...

IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...

The IPO market has become red hot — at least among venture capital–backed biopharma and other life sciences companies. In the ...

In its latest cycle, the Nasdaq Stockholm IPO Pulse turned up in September 2022 – anticipating the September 2023 low in IPO activity – and has since increased to a 2½-year high. That suggests IPO ...

Apple went public in December 1980 at $22 per share. Like pretty much any stock over a nearly 45-year period, Apple stock has ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Initial public offerings (IPOs) can be great opportunities for investors. After all, getting in on a stock on the ground floo ...

Kazakhstan and Nasdaq-listed fintech Kaspi.kz have come out fighting against a short seller’s report that argues the ...

When Rivian Automotive (NASDAQ: RIVN) went public in November 2021, many optimistic investors thought it could become the ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Japanese memory chipmaker Kioxia Holdings Corp. is pushing back plans for an initial public offering until later this year after a downturn in semiconductor stocks. Kioxia ... because the plans are ...

About This EventCyberArk (NASDAQ: CYBR), the identity security company, visits the Nasdaq MarketSite in Times Square to celebrate 10 years since the company’s IPO.In honor of the occasion, Matt Cohen, ...